Keywords: Biomarkers, Contrast Agent
Motivation: Cellular response to cancer treatment is difficult to track in real time. Standard practice involves immunostaining of a biopsied tumor, but this is severely limited by a number of factors.
Goal(s): Non-invasive imaging methods such as MRI could obviate the need for biopsies and serve as a biomarker of radiation therapy efficacy.
Approach: This study aimed to observe macrophage response in a mouse model by use of a fluorine nanoemulsion and 19F MRI.
Results: It was shown that macrophage recruitment can be quantified through MRI. Moreover, the findings suggest that macrophage response to radiation therapy is dependent on several factors including tumor origin.
Impact: Our results demonstrate the potential of 19F MRI to non-invasively track macrophages during radiation therapy and its prognostic value with regards to tumor growth. This technique will be extremely beneficial in future analysis of inflammation’s role in tumor recurrence.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords